Tacogday, Dionesia .

HRN: 04-48-83  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/25/2026
CEFUROXIME 750MG (VIAL)
06/25/2026
07/02/2026
IV
750mg
Q8
Mild TBI
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines